1.Endless Challenges in Overcoming Complications Associated with Endoscopic Submucosal Dissection
Satoshi ONO ; Shun ITO ; Kenji OGATA
Clinical Endoscopy 2019;52(5):395-396
No abstract available.
Endoscopic Mucosal Resection
;
Gastroscopy
;
Dissection
2.Clinical Evaluation of the Patients with Torsade de Pointes.
Tatsuya HONDO ; Nobuyuki MORISHIMA ; Makoto MUNEMORI ; Soichiro YAMASAKI ; Johji SAKURAI ; Satoshi OGATA ; Motohiro YOSHIKAWA ; Humiaki HINO ; Makoto OOBAYASHI
Journal of the Japanese Association of Rural Medicine 1998;46(5):809-813
We treated six patients with torsade de pointes (TdP) initiated by the prolonged QT interval in our hospital over the past five years. All the patients were on antiarrhythmic therapy ; one received procainamide, one received aprindine, one received pirmenol and the remaining three patients received disopyramide. In three of the six patients, the serum drug levels were within or below the therapeutic range. Three patients had hypokalemia as another precipitating factor. Two patients developed TdP after a long-term administration of the drugs. Great care must be exercised just in case TdP showed be developed by a conbination of precipitating factors even after the long-term administration of these antiarrhythmic drugs.
3.Single-Stage Endoscopic Stone Extraction and Cholecystectomy during the Same Hospitalization
Toshiaki TERAUCHI ; Hiroharu SHINOZAKI ; Satoshi SHINOZAKI ; Yuichi SASAKURA ; Masaru KIMATA ; Junji FURUKAWA ; Alan Kawarai LEFOR ; Yoshiro OGATA ; Kenji KOBAYASHI
Clinical Endoscopy 2019;52(1):59-64
BACKGROUND/AIMS: The clinical impact of single-stage endoscopic stone extraction by endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy during the same hospitalization remains elusive. This study aimed to determine the efficacy and safety of single-stage ERCP and cholecystectomy during the same hospitalization in patients with cholangitis. METHODS: We retrospectively reviewed the medical records of 166 patients who underwent ERCP for mild to moderate cholangitis due to choledocholithiasis secondary to cholecystolithiasis from 2012 to 2016. RESULTS: Complete stone extraction was accomplished in 92% of patients (152/166) at the first ERCP. Among 152 patients who underwent complete stone extraction, cholecystectomy was scheduled for 119 patients (78%). Cholecystectomy was performed during the same hospitalization in 89% of patients (106/119). We compared two groups of patients: those who underwent cholecystectomy during the same hospitalization (n=106) and those who underwent cholecystectomy during a subsequent hospitalization (n=13). In the delayed group, cholecystectomy was performed about three months after the first ERCP. There were no significant differences between the groups in terms of operative time, rate of postoperative complications, and interval from cholecystectomy to discharge. CONCLUSIONS: Single-stage endoscopic stone extraction is recommended in patients with mild to moderate acute cholangitis due to choledocholithiasis. The combination of endoscopic stone extraction and cholecystectomy during the same hospitalization is safe and feasible.
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangitis
;
Cholecystectomy
;
Cholecystectomy, Laparoscopic
;
Cholecystolithiasis
;
Choledocholithiasis
;
Hospitalization
;
Humans
;
Medical Records
;
Operative Time
;
Patient Outcome Assessment
;
Postoperative Complications
;
Retrospective Studies
4.Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries.
Taku KOBAYASHI ; Tadakazu HISAMATSU ; Yasuo SUZUKI ; Haruhiko OGATA ; Akira ANDOH ; Toshimitsu ARAKI ; Ryota HOKARI ; Hideki IIJIMA ; Hiroki IKEUCHI ; Yoh ISHIGURO ; Shingo KATO ; Reiko KUNISAKI ; Takayuki MATSUMOTO ; Satoshi MOTOYA ; Masakazu NAGAHORI ; Shiro NAKAMURA ; Hiroshi NAKASE ; Tomoyuki TSUJIKAWA ; Makoto SASAKI ; Kaoru YOKOYAMA ; Naoki YOSHIMURA ; Kenji WATANABE ; Miiko KATAFUCHI ; Mamoru WATANABE ; Toshifumi HIBI
Intestinal Research 2018;16(2):168-177
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gastrointestinal tract, with increasing prevalence worldwide. IBD Ahead is an international educational program that aims to explore questions commonly raised by clinicians about various areas of IBD care and to consolidate available published evidence and expert opinion into a consensus for the optimization of IBD management. Given differences in the epidemiology, clinical and genetic characteristics, management, and prognosis of IBD between patients in Japan and the rest of the world, this statement was formulated as the result of literature reviews and discussions among Japanese experts as part of the IBD Ahead program to consolidate statements of factors for disease prognosis in IBD. Evidence levels were assigned to summary statements in the following categories: disease progression in CD and UC; surgery, hospitalization, intestinal failure, and permanent stoma in CD; acute severe UC; colectomy in UC; and colorectal carcinoma and dysplasia in IBD. The goal is that this statement can aid in the optimization of the treatment strategy for Japanese patients with IBD and help identify high-risk patients that require early intervention, to provide a better long-term prognosis in these patients.
Asian Continental Ancestry Group
;
Colectomy
;
Colitis, Ulcerative
;
Colorectal Neoplasms
;
Consensus
;
Crohn Disease
;
Disease Management*
;
Disease Progression
;
Early Intervention (Education)
;
Epidemiology
;
Expert Testimony
;
Gastrointestinal Tract
;
Hospitalization
;
Humans
;
Inflammatory Bowel Diseases*
;
Japan*
;
Prevalence
;
Prognosis